Business Description
Sophia Genetics SA
ISIN : CH1125843347
Total Employee Number:
415Description
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.05 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.37 | |||||
Debt-to-EBITDA | -0.97 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -3.05 | |||||
Beneish M-Score | -3.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.5 | |||||
3-Year EBITDA Growth Rate | 9.6 | |||||
3-Year EPS without NRI Growth Rate | 5.9 | |||||
3-Year FCF Growth Rate | 19.3 | |||||
3-Year Book Growth Rate | -39.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 26.09 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 21.86 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.34 | |||||
9-Day RSI | 47.56 | |||||
14-Day RSI | 50.91 | |||||
3-1 Month Momentum % | -4.17 | |||||
6-1 Month Momentum % | 6.15 | |||||
12-1 Month Momentum % | 62.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.06 | |||||
Quick Ratio | 1.9 | |||||
Cash Ratio | 1.4 | |||||
Days Inventory | 86.25 | |||||
Days Sales Outstanding | 49.51 | |||||
Days Payable | 99.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.2 | |||||
Shareholder Yield % | -10.5 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.28 | |||||
Operating Margin % | -88.88 | |||||
Net Margin % | -99.7 | |||||
EBITDA Margin % | -79 | |||||
FCF Margin % | -61.97 | |||||
OCF Margin % | -49.65 | |||||
ROE % | -128.13 | |||||
ROA % | -50.1 | |||||
ROIC % | -90.34 | |||||
3-Year ROIIC % | 45.76 | |||||
ROC (Joel Greenblatt) % | -411.97 | |||||
ROCE % | -60.71 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.53 | |||||
PB Ratio | 8.42 | |||||
Price-to-Tangible-Book | 38.5 | |||||
EV-to-EBIT | -6.02 | |||||
EV-to-EBITDA | -6.96 | |||||
EV-to-Revenue | 5.5 | |||||
EV-to-Forward-Revenue | 3.06 | |||||
EV-to-FCF | -8.88 | |||||
Price-to-GF-Value | 1.06 | |||||
Earnings Yield (Greenblatt) % | -16.61 | |||||
FCF Yield % | -11.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sophia Genetics SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 69.766 | ||
| EPS (TTM) (€) | -1.015 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 46.33 | ||
| 14-Day RSI | 50.91 | ||
| 14-Day ATR (€) | 0.162269 | ||
| 20-Day SMA (€) | 4.613 | ||
| 12-1 Month Momentum % | 62.99 | ||
| 52-Week Range (€) | 2.46 - 5.3 | ||
| Shares Outstanding (Mil) | 83.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sophia Genetics SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sophia Genetics SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 08:00 | In 122 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 121 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 08:00 | In 31 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 30 days | ||
| General meeting for 2026 | 2026-06-18 | 4.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 08:00 | 4.46 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 4.46 (+0.00%) | ||
| 46th Annual TD Cowen Health Care Conference PR Newswire | 2026-03-04 10:30 | 3.90 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-03 08:00 | 3.74 (+0.00%) | ||
| Annual report for 2025 | 2026-03-03 | 3.74 (+0.00%) |
Show
Entries
Sophia Genetics SA Frequently Asked Questions
What is Sophia Genetics SA(FRA:90B)'s stock price today?
The current price of FRA:90B is €4.62. The 52 week high of FRA:90B is €5.30 and 52 week low is €2.46.
When is next earnings date of Sophia Genetics SA(FRA:90B)?
The next earnings date of Sophia Genetics SA(FRA:90B) is 2026-08-05 Est..
Does Sophia Genetics SA(FRA:90B) pay dividends? If so, how much?
Sophia Genetics SA(FRA:90B) does not pay dividend.
Press Release
Articles on Sophia Genetics SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers